Cargando…

Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care

The use of long-acting lipoglycopeptides (LaLGPs) in serious, deep-seated infections is of increasing interest. The purpose of this study is to evaluate the economic and clinical utility of LaLGPs in patients requiring protracted antibiotic courses who are not ideal candidates for oral transition or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antosz, Kayla, Al-Hasan, Majdi N., Lu, Z. Kevin, Tabor, Benjamin, Justo, Julie Ann, Milgrom, Alexander, Kohn, Joseph, Bookstaver, P. Brandon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788434/ https://www.ncbi.nlm.nih.gov/pubmed/35076601 http://dx.doi.org/10.3390/pharmacy10010001

Ejemplares similares

44. Cost Effectiveness and Clinical Outcomes of Long Acting Lipoglycopeptides Used in Transitions of Care for Deep-Seated Infections
por: Antosz, Kayla S, et al.
Publicado: (2021)

Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)
por: Winders, Hana R., et al.
Publicado: (2022)

Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
por: Foster, Rachel A., et al.
Publicado: (2019)

851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection
por: Elizabeth. Battle, Sarah, et al.
Publicado: (2019)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection
por: Amipara, Rajiv, et al.
Publicado: (2021)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection
por: Powers, Caroline, et al.
Publicado: (2019)

Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
por: Al-Hasan, Majdi N., et al.
Publicado: (2019)

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
por: Morrisette, Taylor, et al.
Publicado: (2019)

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

290. Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections
por: Amipara, Rajiv G, et al.
Publicado: (2020)

313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections
por: McDougal, Elizabeth, et al.
Publicado: (2020)

617. Long Acting Lipoglycopeptide Use in Veterans for Serious Gram-Positive Infections in the COVID Era
por: Saldana, Carlos S, et al.
Publicado: (2021)

Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System
por: Shealy, Stephanie, et al.
Publicado: (2021)

Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series
por: Warren, Erin F, et al.
Publicado: (2022)

1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
por: Pizzuti, Morgan, et al.
Publicado: (2021)

Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system
por: O’Neal, Melissa, et al.
Publicado: (2020)

Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report
por: Jones, Jordan, et al.
Publicado: (2022)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics
por: Metzger, Brian S, et al.
Publicado: (2020)

2399. Changing Demographics of Infective Endocarditis in South Carolina: An Ecological Study
por: Garrison, Phillip G, et al.
Publicado: (2023)

1388. Epidemiology and Treatment Outcomes of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
por: Vivian Tsai, Y, et al.
Publicado: (2021)

Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
por: Tsai, Yuwei Vivian, et al.
Publicado: (2022)

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases
por: Datta, Rupak, et al.
Publicado: (2018)

Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics
por: Eckmann, Christian, et al.
Publicado: (2021)

Antibiotic lock therapy: review of technique and logistical challenges
por: Justo, Julie Ann, et al.
Publicado: (2014)

Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
por: Shealy, Stephanie C., et al.
Publicado: (2020)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

2733. Association Between Influenza Vaccination Coverage and Ambulatory Antibiotic Prescription Rates in Children in South Carolina
por: Younas, Mariam, et al.
Publicado: (2019)

Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study
por: Winders, Hana R., et al.
Publicado: (2021)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
por: Jafari Saraf, Lida, et al.
Publicado: (2011)

Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)

231. Retrospective Comparison of Intravenous Therapy, Oral Therapy, and Lipoglycopeptides for the Treatment of Osteomyelitis
por: Stumphauzer, Alex, et al.
Publicado: (2021)

Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A
por: Poshvina, Darya V., et al.
Publicado: (2022)

243. Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina
por: Winders, Hana R, et al.
Publicado: (2020)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bptf7ne19vr5al06kb2hd2e99v